Bovine cutaneous fibropapillomas are benign skin tumours characterized by epithelial and dermal proliferation and induced by Bovine papillomaviruses (BPVs). Cyclooxygenase (COX) 1 and 2 are enzymes involved in pathological conditions, such as inflammation and epithelial carcinogenesis. Here we investigated biochemically and immunohistochemically COX-2 expression in bovine cutaneous fibropapillomas. Eight of twelve fibropapillomas (67%) showed COX-2 positive immunosignal mostly in the cytoplasm of the basal cell layer, while the normal skin did not stain. Biochemical analysis confirmed the expression of COX-2 in tumour samples. This study shows COX-2 expression in cutaneous fibropapillomas, suggesting a contribution in epithelial tumour development.
Introduction
Bovine cutaneous fibropapillomas are benign hyperproliferative tumors affecting cattle worldwide, induced by Bovine papillomaviruses (BPVs) (Nasir and Campo 2008) . Cyclooxygenases (COXs) are enzymes demonstrated to exist as two distinct isoforms. The COX-1 isoform is expressed constitutively in many cells, whereas COX-2 expression is generally undetectable in most healthy adult epithelial tissues, but can be highly induced by multiple mitogenic and inflammatory stimuli (Dore 2011) . Recent studies demCorrespondence to: G. Borzacchiello, e-mail: borzacch@unina.it, tel.: 00 39 081 253 64 67 * These two authors contributed equally to this work onstrated COX-2 expression in a variety of animal tumors (Beam et al. 2003 , Borzacchiello et al. 2004 , Thamm et al. 2008 ). Moreover, COX-2 overexpression has been demonstrated in both human and animal papillomavirus induced tumours (Borzacchiello et al. 2003 , Balan et al. 2011 . The purpose of this study was to investigate COX-2 expression in spontaneous bovine cutaneous fibropapillomas. 
Materials and Methods
Thirteen fibropapilloma samples (T1-T13) from cattle with clear clinical signs of cutaneous fibropapillomatosis were collected under local anesthesia from a dairy farm from Moldova, Romania. The animals aged 8 months to 4 years and were all Romanian Black Spotted breed. Also two samples of normal skin (N1-N2) from healthy cows were obtained at a public slaughterhouse. To investigate the specificity of the antibody, protein lysates from six fibropapillomas (T1-T5, T13) and two normal skin (N1-N2) frozen samples were analysed by Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) and Western blot. An anti-COX-2 primary antibody (VP-RM02, Vector Laboratories) was used.
Further, the bovine cutaneous fibropapilloma samples (T1-T12) and normal skin samples (N1-N2) were evaluated by immunohistochemistry. Sample T13 was not available for immunohistochemical analysis. Briefly, tissue sections were stained using the same anti-COX-2 primary antibody and the streptavidin-biotin-peroxidase (LSAB kit, Dako Cytomation, Denmark) method. A positive control represented by human breast cancer was run in parallel. The scoring of the immunoreactivity was determined in a "blind" study by two observers (FB and GB). The intensity of intracellular brown labelling in each specimen was scored on a four-tiered scale of 0 to +++ as follows: 0, absent; +, weak; ++, moderate and +++, strong.
Results and Discussion
By Western blot analysis, the antibody recognized a band of the expected molecular mass in three neoplastic tissues but not in the normal skin (data not shown).
By immunohistochemistry, COX-2 immunoreactivity was not detected in normal skin samples (Fig.  1A) . Eight of twelve tumour samples (67%) were COX-2 positive. The immunosignal was recorded in the cytoplasm of the basal cells layer (Fig. 1C) , with increased intensity in the perinuclear area (Fig. 1D) . Staining was heterogeneous throughout tumour sections. Sporadically, few cells in the superficial layer showed moderate cytoplasmic immunoreactivity. The results of COX-2 immunoreactivity are provided in Table 1 . COX-2 was expressed also by the fibroblasts beneath the epithelial proliferation in six out of twelve (50%) fibropapilloma samples, showing a moderate cytoplasmic immunosignal. The positive control represented by human breast cancer showed a strong cytoplasmic staining (Fig. 1B) .
Our results show that COX-2 is expressed in bovine cutaneous fibropapillomas.
Interestingly, it has been reported that COX-2 is overexpressed in equine, feline and canine epithelial tumours (Borzacchiello et al. 2004 , Bardagi et al. 2012 , indicating that COX-2 is involved in animal tumour development. Futhermore, COX-2 is overexpressed in spontaneous bovine and equine tumours caused by BPV infection (Borzacchiello et al. 2003 , Thamm et al. 2008 , suggesting that COX-2 expression is a common finding in BPV-induced tumours. Here, we show a cytoplasmic localization of COX-2 in the basal cell layer. Similar findings were also reported in other studies conducted on epithelial tumors with different etiology in animal species, where COX-2 cytoplasmic expression may be important for its function in tumour development independently of the cause of cancerogenesis (Beam et al. 2003 , Borzacchiello et al. 2004 , Kleiter et al. 2004 ). The COX-2 perinuclear pattern frequently observed in some of our tumour samples has been also observed in some human and canine cancers (Ristimaki et al. 2001 , Borzacchiello et al. 2004 ) and may be related to COX-2 subcellular distribution (Morita et al. 1995) .
Additionally, COX-2 is overexpressed in Human Papillomavirus (HPV) induced cervical carcinomas, denoting a possible interplay between the PVs and COX-2 expression (Balan et al. 2011) . Finally, this study shows for the first time, to the best of the authors' knowledge, that COX-2 is expressed in cutaneous fibropapillomas, suggesting a contribution of this enzyme to epithelial tumour development. However, the precise role of COX-2 expression in the development of bovine cutaneous tumours induced by BPVs needs further investigations.
